Início › DPOC › Carolina do Sul

Ensaios clínicos de DPOC em Carolina do Sul

14 estudos para DPOC estão buscando participantes em locais em Carolina do Sul.

Cidades em Carolina do Sul

Texto oficial do estudo (Inglês)

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Research Site, Anderson
Research Site, Charleston
Research Site, Gaffney
e mais 2

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

MedTrial- Site Number : 8400010, Columbia

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07190222

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

Clinical Research of Rock Hill, Rock Hill

RecrutandoFase 2

Idades de 40 a 85 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07684820

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

AnMed Oglesby Center- Site Number : 8400074, Anderson
MD First Research - Lancaster- Site Number : 8400102, Lancaster

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07190209

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Research Site, Lancaster
Research Site, Spartanburg

RecrutandoFase 2

Idades 40 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07082738

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Research Site, Anderson
Research Site, Columbia
Research Site, Gaffney
e mais 2

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Research Site, Rock Hill

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Bogan Sleep Consultants, LLC, Columbia
Velocity Clinical Research, Gaffney, Gaffney
Clinical Research of Rock Hill, Rock Hill
e mais 1

RecrutandoFase 2/3

Idades de 35 a 80 · Todos os sexos · Atualizado em 31 de ago. de 2026 · NCT07363694

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

GC2501 Study Site 101, Charleston

RecrutandoFase 3

Idades de 18 a 80 · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT07555483

STRIVE Post-Market Registry Study

AnMed Health, Anderson

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

GSK Investigational Site, Greenville
GSK Investigational Site, Rock Hill

RecrutandoFase 3

Idades de 40 a 75 · Todos os sexos · Atualizado em 28 de jul. de 2026 · NCT07177339

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

GSK Investigational Site, Spartanburg
GSK Investigational Site, Union

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 9 de abr. de 2026 · NCT06961214

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

GSK Investigational Site, Rock Hill

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 8 de out. de 2025 · NCT06959095

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Medical University of South Carolina (MUSC), Charleston
McLeod Health, Florence

RecrutandoEstudo observacional

Idades 50 e acima · Todos os sexos · Atualizado em 5 de ago. de 2025 · NCT06122077

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.